{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:47:00Z","timestamp":1785851220035,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Fujian Medical University Union Hospital Talent Launch Fund Project","award":["2024XH007"],"award-info":[{"award-number":["2024XH007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04439-8","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T03:45:44Z","timestamp":1780285544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune-inflammatory-fibrinogen score as a novel prognostic biomarker in patients with gastric cancer undergoing radical gastrectomy: a multicenter study"],"prefix":"10.1186","volume":"24","author":[{"given":"Wei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Ming","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"3","key":"4439_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"issue":"3","key":"4439_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel R, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"issue":"1","key":"4439_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1186\/s12889-024-19104-6","volume":"24","author":"J Lin","year":"2024","unstructured":"Lin J, Lin J, Lin G, et al. Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035. BMC Public Health. 2024;24(1):1763. https:\/\/doi.org\/10.1186\/s12889-024-19104-6.","journal-title":"BMC Public Health"},{"issue":"3","key":"4439_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s10120-025-01601-1","volume":"28","author":"Y Ushimaru","year":"2025","unstructured":"Ushimaru Y, Omori T, Yamamoto K, et al. Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes. Gastric cancer: official J Int Gastric Cancer Association Japanese Gastric Cancer Association. 2025;28(3):514\u201326. https:\/\/doi.org\/10.1007\/s10120-025-01601-1.","journal-title":"Gastric cancer: official J Int Gastric Cancer Association Japanese Gastric Cancer Association"},{"issue":"3","key":"4439_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.21147\/j.issn.1000-9604.2025.03.07","volume":"37","author":"Y Pan","year":"2025","unstructured":"Pan Y, Lu L, Gao X, et al. Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study. Chin J cancer Res = Chung-kuo yen cheng yen chiu. 2025;37(3):377\u201389. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.03.07.","journal-title":"Chin J cancer Res = Chung-kuo yen cheng yen chiu"},{"key":"4439_CR6","doi-asserted-by":"crossref","unstructured":"Jung W, Kim J, Lee H et al. Impact of resection margin status on survival in gastric cancer: A retrospective cohort study. Chinese journal of cancer research\u2009=\u2009Chung-kuo yen cheng yen chiu. 2025;37(5):821\u20133610.21147\/j.issn.1000-9604.2025.05.12","DOI":"10.21147\/j.issn.1000-9604.2025.05.12"},{"key":"4439_CR7","doi-asserted-by":"publisher","unstructured":"Fang J, Yu Y, Sun Y, et al. Longitudinal plasma proteome profiling identifies IFN-gamma dynamics as a time-dependent predictor of immunotherapy response in advanced gastric cancer. BMC Cancer. 2026;26(1). https:\/\/doi.org\/10.1186\/s12885-026-15623-0.","DOI":"10.1186\/s12885-026-15623-0"},{"issue":"7","key":"4439_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang Y. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends cancer. 2024;10(7):627\u201342. https:\/\/doi.org\/10.1016\/j.trecan.2024.03.008.","journal-title":"Trends cancer"},{"key":"4439_CR9","doi-asserted-by":"crossref","unstructured":"Luo D, Zhou J, Ruan S et al. Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies. Cell death & disease. 2025;16(1):75.doi:9.10.1038\/s41419-025-07385-7.","DOI":"10.1038\/s41419-025-07385-7"},{"issue":"5","key":"4439_CR10","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1245\/s10434-026-19241-9","volume":"33","author":"J Kim","year":"2026","unstructured":"Kim J, Lee H, Kang M, et al. Persistent Systemic Inflammation Mediates the Impact of Postoperative Complications on Survival After Gastric Cancer Surgery. Ann Surg Oncol. 2026;33(5):4702\u201313. https:\/\/doi.org\/10.1245\/s10434-026-19241-9.","journal-title":"Ann Surg Oncol"},{"key":"4439_CR11","doi-asserted-by":"publisher","first-page":"1622959","DOI":"10.3389\/fimmu.2025.1622959","volume":"16","author":"P Jin","year":"2025","unstructured":"Jin P, Ji X, Bai J, et al. Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer. Front Immunol. 2025;16:1622959. https:\/\/doi.org\/10.3389\/fimmu.2025.1622959.","journal-title":"Front Immunol"},{"key":"4439_CR12","doi-asserted-by":"publisher","unstructured":"Deng J, Liu J, Wang W et al. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chinese journal of cancer research\u2009=\u2009Chung-kuo yen cheng yen chiu. 2018;30(5):477\u201391.https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2018.05.01","DOI":"10.21147\/j.issn.1000-9604.2018.05.01"},{"key":"4439_CR13","doi-asserted-by":"crossref","unstructured":"Zhang T, Sun Z, Li Z et al. Computational pathology approach for assessment of prognosis and immunotherapy response in pan-gastrointestinal cancer. Journal of translational medicine. 2025;23(1):1088.doi:13.10.1186\/s12967-025-06181-3.","DOI":"10.1186\/s12967-025-06181-3"},{"issue":"8","key":"4439_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/cac2.70032","volume":"45","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Zhang S, Han L, et al. First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial. Cancer Commun (London England). 2025;45(8):990\u20131009. https:\/\/doi.org\/10.1002\/cac2.70032.","journal-title":"Cancer Commun (London England)"},{"issue":"12","key":"4439_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41416-025-03015-3","volume":"132","author":"J Li","year":"2025","unstructured":"Li J, Tao M, Liu L, et al. Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer. Br J Cancer. 2025;132(12):1167\u201376. https:\/\/doi.org\/10.1038\/s41416-025-03015-3.","journal-title":"Br J Cancer"},{"issue":"12","key":"4439_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00262-025-04237-3","volume":"74","author":"W Zhang","year":"2025","unstructured":"Zhang W, Gong C, Huang J, et al. Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR\/MSS refractory metastatic colorectal cancer: a phase 2 clinical trial. Cancer Immunol immunotherapy: CII. 2025;74(12):381. https:\/\/doi.org\/10.1007\/s00262-025-04237-3.","journal-title":"Cancer Immunol immunotherapy: CII"},{"key":"4439_CR17","doi-asserted-by":"publisher","first-page":"104625","DOI":"10.1016\/j.critrevonc.2025.104625","volume":"207","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li Z, Zhang J, et al. Fibrinogen: A new player and target on the formation of pre-metastatic niche in tumor metastasis. Crit Rev Oncol\/Hematol. 2025;207:104625. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104625.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"4","key":"4439_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.gastro.2025.09.024","volume":"170","author":"N Chowdhury","year":"2026","unstructured":"Chowdhury N, Mitchell D, Kangro K, et al. Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. Gastroenterology. 2026;170(4):753\u201368. https:\/\/doi.org\/10.1053\/j.gastro.2025.09.024.","journal-title":"Gastroenterology"},{"key":"4439_CR19","doi-asserted-by":"publisher","first-page":"1605976","DOI":"10.3389\/fimmu.2025.1605976","volume":"16","author":"L Zhu","year":"2025","unstructured":"Zhu L, Ruan J, Zhang Q, et al. LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysis. Front Immunol. 2025;16:1605976. https:\/\/doi.org\/10.3389\/fimmu.2025.1605976.","journal-title":"Front Immunol"},{"issue":"3","key":"4439_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.21037\/hbsn-23-502","volume":"14","author":"X Hu","year":"2025","unstructured":"Hu X, Zeng D, Wen N, et al. Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis. Hepatobiliary Surg Nutr. 2025;14(3):374\u201397. https:\/\/doi.org\/10.21037\/hbsn-23-502.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"4439_CR21","doi-asserted-by":"publisher","first-page":"1737375","DOI":"10.3389\/fnut.2026.1737375","volume":"13","author":"Y Huang","year":"2026","unstructured":"Huang Y, Zhang J, Ge Y, et al. Association between systemic inflammation biomarkers and cancer cachexia in patients with gastric cancer: a cross-sectional study. Front Nutr. 2026;13:1737375. https:\/\/doi.org\/10.3389\/fnut.2026.1737375.","journal-title":"Front Nutr"},{"issue":"1","key":"4439_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13048-025-01631-4","volume":"18","author":"J Chen","year":"2025","unstructured":"Chen J, Jin L, Luo R, et al. Predictive value of preoperative systemic immune-inflammation index and prognostic nutrition index in patients with epithelial ovarian cancer. J ovarian Res. 2025;18(1):45. https:\/\/doi.org\/10.1186\/s13048-025-01631-4.","journal-title":"J ovarian Res"},{"key":"4439_CR23","doi-asserted-by":"crossref","unstructured":"Du Y, Li Y, Tan Z et al. Prognostic value of combining preoperative immune-inflammatory-nutritional index and tumor biomarkers in gastric cancer patients undergoing radical resection. Frontiers in nutrition. 2025;12:1562202.doi:23.10.3389\/fnut.2025.1562202.","DOI":"10.3389\/fnut.2025.1562202"},{"issue":"1","key":"4439_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10120-003-0267-y","volume":"7","author":"T Ichikura","year":"2004","unstructured":"Ichikura T, Ogawa T, Majima T, et al. Evaluation of the Japanese Gastric Cancer Association\u2019s Gastric cancer treatment guidelines for popular use. Gastric Cancer. 2004;7(1):41\u20135. https:\/\/doi.org\/10.1007\/s10120-003-0267-y.","journal-title":"Gastric Cancer"},{"key":"4439_CR25","doi-asserted-by":"publisher","unstructured":"Japanese gastric cancer treatment guidelines. 2010 (ver. 3). Gastric Cancer. 2011;14(2):113\u2013123. https:\/\/doi.org\/10.1007\/s10120-011-0042-4.","DOI":"10.1007\/s10120-011-0042-4"},{"key":"4439_CR26","doi-asserted-by":"publisher","unstructured":"Japanese gastric cancer treatment guidelines. 2014 (ver. 4). Gastric Cancer. 2017;20(1):1\u201319. https:\/\/doi.org\/10.1007\/s10120-016-0622-4.","DOI":"10.1007\/s10120-016-0622-4"},{"key":"4439_CR27","doi-asserted-by":"publisher","unstructured":"Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1\u201321. https:\/\/doi.org\/10.1007\/s10120-020-01042-y.","DOI":"10.1007\/s10120-020-01042-y"},{"key":"4439_CR28","doi-asserted-by":"publisher","first-page":"105595doi","DOI":"10.1016\/j.ebiom.2025.105595","volume":"113","author":"Y Cui","year":"2025","unstructured":"Cui Y, Zhang J, Wang Y, et al. Multivariate predictive model of the therapeutic effects of metoprolol in paediatric vasovagal syncope: a multi-centre study. EBioMedicine. 2025;113:105595doi. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105595.","journal-title":"EBioMedicine"},{"key":"4439_CR29","doi-asserted-by":"publisher","first-page":"1759292","DOI":"10.3389\/fimmu.2026.1759292","volume":"17","author":"Z Sun","year":"2026","unstructured":"Sun Z, Wang Z, Liu R, et al. A personalized prognostic model based on preoperative body composition and nutritional parameters for gastric cancer patients receiving neoadjuvant chemotherapy. Front Immunol. 2026;17:1759292. https:\/\/doi.org\/10.3389\/fimmu.2026.1759292.","journal-title":"Front Immunol"},{"issue":"8","key":"4439_CR30","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.62347\/ZWXU9375","volume":"15","author":"X Hu","year":"2025","unstructured":"Hu X, Zhou L, Lin R. Systemic immune-inflammation index and lymphocyte-to-monocyte ratio predict recurrence after radical surgery for stage I\/II endometrial cancer. Am J cancer Res. 2025;15(8):3471\u201385. https:\/\/doi.org\/10.62347\/ZWXU9375.","journal-title":"Am J cancer Res"},{"key":"4439_CR31","doi-asserted-by":"publisher","first-page":"1327281","DOI":"10.3389\/fimmu.2024.1327281","volume":"15","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Lu G, Li N, et al. Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment. Front Immunol. 2024;15:1327281. https:\/\/doi.org\/10.3389\/fimmu.2024.1327281.","journal-title":"Front Immunol"},{"issue":"7","key":"4439_CR32","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.62347\/ZBGU2008","volume":"15","author":"X Zhou","year":"2025","unstructured":"Zhou X, Wang S, Shi J. Prognostic value of immunoinflammatory indicators and tumor markers for first-line chemotherapy in patients with non-small cell lung cancer. Am J cancer Res. 2025;15(7):3209\u201318. https:\/\/doi.org\/10.62347\/ZBGU2008.","journal-title":"Am J cancer Res"},{"issue":"4","key":"4439_CR33","doi-asserted-by":"publisher","first-page":"e70570","DOI":"10.1111\/liv.70570","volume":"46","author":"T Matono","year":"2026","unstructured":"Matono T, Tada T, Hiraoka A, et al. Lymphocyte-Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab. Liver international: official J Int Association Study Liver. 2026;46(4):e70570. https:\/\/doi.org\/10.1111\/liv.70570.","journal-title":"Liver international: official J Int Association Study Liver"},{"key":"4439_CR34","doi-asserted-by":"publisher","unstructured":"Jiang C, Li Y, Li Y et al. Fibrinogen promotes gallbladder cancer cell metastasis and extravasation by inducing ICAM1 expression. Medical oncology (Northwood, London, England). 2022;40(1):10.https:\/\/doi.org\/10.1007\/s12032-022-01874-x","DOI":"10.1007\/s12032-022-01874-x"},{"key":"4439_CR35","doi-asserted-by":"publisher","first-page":"106687","DOI":"10.1016\/j.ejim.2025.106687","volume":"146","author":"M Sogbe","year":"2026","unstructured":"Sogbe M, Park S, Bromfield B, et al. Inflammatory spectrum of frailty: Association between the systemic immune-inflammation index and frailty in liver transplant candidates. Eur J Intern Med. 2026;146:106687. https:\/\/doi.org\/10.1016\/j.ejim.2025.106687.","journal-title":"Eur J Intern Med"},{"key":"4439_CR36","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.2147\/JIR.S523882","volume":"18","author":"Z Liu","year":"2025","unstructured":"Liu Z, Liu H, Zhang Y, et al. Prognostic Enhancement in Gastric Cancer Through the Integration of Inflammatory Indices into the pTNM-Inflammation Staging System (pTNM-I). J Inflamm Res. 2025;18:11869\u201382. https:\/\/doi.org\/10.2147\/JIR.S523882.","journal-title":"J Inflamm Res"},{"issue":"2","key":"4439_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.62347\/EHDB3254","volume":"16","author":"Z He","year":"2026","unstructured":"He Z, Lai J, Lin W, et al. Prognostic value of the lactate dehydrogenase-to-albumin ratio (LAR) combined with clinicopathological indicators for predicting outcomes in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study and nomogram development. Am J cancer Res. 2026;16(2):470\u201395. https:\/\/doi.org\/10.62347\/EHDB3254.","journal-title":"Am J cancer Res"},{"key":"4439_CR38","doi-asserted-by":"crossref","unstructured":"Barbui T, Ghirardi A, Empson V et al. Neutrophil-to-Lymphocyte ratio as surrogate for JAK2 suppression and event-free survival in polycythemia vera. Blood cancer journal. 2025;15(1):132.doi:36.10.1038\/s41408-025-01317-6.","DOI":"10.1038\/s41408-025-01317-6"},{"key":"4439_CR39","doi-asserted-by":"crossref","unstructured":"Tan S, Zheng Q, Zhang W et al. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Frontiers in immunology. 2024;15:1408700.doi:37.10.3389\/fimmu.2024.1408700.","DOI":"10.3389\/fimmu.2024.1408700"},{"key":"4439_CR40","doi-asserted-by":"publisher","first-page":"897218","DOI":"10.3389\/fonc.2022.897218","volume":"12","author":"L Marano","year":"2022","unstructured":"Marano L, Ambrosio M, Resca L, et al. The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer. Front Oncol. 2022;12:897218. https:\/\/doi.org\/10.3389\/fonc.2022.897218.","journal-title":"Front Oncol"},{"issue":"3","key":"4439_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejso.2021.09.003","volume":"48","author":"F Roviello","year":"2022","unstructured":"Roviello F, Marano L, Ambrosio M, et al. Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2022;48(3):561\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2021.09.003.","journal-title":"Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"key":"4439_CR42","doi-asserted-by":"publisher","unstructured":"Yan H, Liu Y. Advances in Spatial Multi-Omics in Gastric Cancer. Cells. 2026;15(6). https:\/\/doi.org\/10.3390\/cells15060535.","DOI":"10.3390\/cells15060535"},{"key":"4439_CR43","doi-asserted-by":"publisher","first-page":"537140","DOI":"10.3389\/fonc.2021.537140","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Zhang Z, Chen Y. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis. Front Oncol. 2021;11:537140. https:\/\/doi.org\/10.3389\/fonc.2021.537140.","journal-title":"Front Oncol"},{"issue":"4","key":"4439_CR44","doi-asserted-by":"publisher","first-page":"103128","DOI":"10.4251\/wjgo.v17.i4.103128","volume":"17","author":"U Sundararaju","year":"2025","unstructured":"Sundararaju U, Rajakumar H. Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer: Enhancing clinical relevance. World J Gastrointest Oncol. 2025;17(4):103128. https:\/\/doi.org\/10.4251\/wjgo.v17.i4.103128.","journal-title":"World J Gastrointest Oncol"},{"key":"4439_CR45","doi-asserted-by":"publisher","unstructured":"Yuan J, Zhao X, Li Y, et al. The Association between Blood Indexes and Immune Cell Concentrations in the Primary Tumor Microenvironment Predicting Survival of Immunotherapy in Gastric Cancer. Cancers. 2022;14(15). https:\/\/doi.org\/10.3390\/cancers14153608.","DOI":"10.3390\/cancers14153608"},{"issue":"1","key":"4439_CR46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.asjsur.2022.04.075","volume":"46","author":"R \u00c7a\u011flar","year":"2023","unstructured":"\u00c7a\u011flar R. The relationship of different preoperative inflammatory markers with the prognosis of gastric carcinoma. Asian J Surg. 2023;46(1):360\u20135. https:\/\/doi.org\/10.1016\/j.asjsur.2022.04.075.","journal-title":"Asian J Surg"},{"issue":"1","key":"4439_CR47","doi-asserted-by":"publisher","first-page":"25336","DOI":"10.1038\/s41598-025-09707-3","volume":"15","author":"M Mildanoglu","year":"2025","unstructured":"Mildanoglu M, Kutlu Y, Bas O, et al. Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score\u2009\u2265\u20095: Turkish Oncology Group (TOG) study. Sci Rep. 2025;15(1):25336. https:\/\/doi.org\/10.1038\/s41598-025-09707-3.","journal-title":"Sci Rep"},{"issue":"1","key":"4439_CR48","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1038\/s41598-024-57814-4","volume":"14","author":"W Xu","year":"2024","unstructured":"Xu W, Liu X, Yan C, et al. The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer. Sci Rep. 2024;14(1):7568. https:\/\/doi.org\/10.1038\/s41598-024-57814-4.","journal-title":"Sci Rep"},{"issue":"8","key":"4439_CR49","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.21037\/tau-23-133","volume":"12","author":"K Sun","year":"2023","unstructured":"Sun K, Zhang J, Chen Y, et al. A dynamic nomogram integrated with blood inflammation markers for predicting overall survival in patients with upper tract urothelial carcinoma. Translational Androl Urol. 2023;12(8):1259\u201372. https:\/\/doi.org\/10.21037\/tau-23-133.","journal-title":"Translational Androl Urol"},{"issue":"12","key":"4439_CR50","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1007\/s11255-025-04553-8","volume":"57","author":"X Jiang","year":"2025","unstructured":"Jiang X, Zhou T, Liu C, et al. Predicting the prognosis of patients with renal cell carcinoma based on systemic immune inflammatory index and prognostic nutritional index. Int Urol Nephrol. 2025;57(12):3975\u201384. https:\/\/doi.org\/10.1007\/s11255-025-04553-8.","journal-title":"Int Urol Nephrol"},{"issue":"30","key":"4439_CR51","doi-asserted-by":"publisher","first-page":"108431","DOI":"10.3748\/wjg.v31.i30.108431","volume":"31","author":"S Demirli Atici","year":"2025","unstructured":"Demirli Atici S, Canda A, Terzi M. Integrating inflammation, nutrition, and artificial intelligence: A new era in colorectal cancer prognostic scoring. World J Gastroenterol. 2025;31(30):108431. https:\/\/doi.org\/10.3748\/wjg.v31.i30.108431.","journal-title":"World J Gastroenterol"},{"key":"4439_CR52","doi-asserted-by":"crossref","unstructured":"Guo Y, Zhong Q, Xie L et al. Development of a new TNM staging system for poorly differentiated thyroid carcinoma: a multicenter cohort study. Frontiers in endocrinology. 2025;16:1586542.doi:50.10.3389\/fendo.2025.1586542.","DOI":"10.3389\/fendo.2025.1586542"},{"issue":"1","key":"4439_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40880-018-0340-x","volume":"38","author":"Z Li","year":"2018","unstructured":"Li Z, Ornellas A, Schwentner C, et al. A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer. Cancer Commun (London England). 2018;38(1):68. https:\/\/doi.org\/10.1186\/s40880-018-0340-x.","journal-title":"Cancer Commun (London England)"},{"key":"4439_CR54","doi-asserted-by":"crossref","unstructured":"Tee M, Pirozzi N, Brahmbhatt R et al. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020;46:1941\u20131947.doi:52.10.1016\/j.ejso.2020.05.014.","DOI":"10.1016\/j.ejso.2020.05.014"},{"key":"4439_CR55","unstructured":"De Felice F, Cattaneo C, Poto G et al. Mapping the landscape of immunonutrition and cancer research: a comprehensive bibliometric analysis on behalf of NutriOnc Research Group. International journal of surgery (London, England). 2024;110(1):395\u2013405.doi:53.10.1097\/JS9.0000000000000783."},{"key":"4439_CR56","doi-asserted-by":"publisher","unstructured":"Poniewierska-Baran A, Sobolak K, Nied\u017awiedzka-Rystwej P, et al. Immunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer-Narrative Review. Int J Mol Sci. 2024;25(12). https:\/\/doi.org\/10.3390\/ijms25126471.","DOI":"10.3390\/ijms25126471"},{"key":"4439_CR57","doi-asserted-by":"publisher","first-page":"703doi","DOI":"10.1186\/s12885-015-1757-0","volume":"15","author":"V Boccardi","year":"2015","unstructured":"Boccardi V, Marano L, Rossetti R, et al. Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker. BMC Cancer. 2015;15:703doi. https:\/\/doi.org\/10.1186\/s12885-015-1757-0.","journal-title":"BMC Cancer"},{"key":"4439_CR58","doi-asserted-by":"publisher","unstructured":"Ozkerim U, Kinikoglu O, Oksuz S, et al. Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study. Med (Kaunas Lithuania). 2026;62(1). https:\/\/doi.org\/10.3390\/medicina62010099.","DOI":"10.3390\/medicina62010099"},{"key":"4439_CR59","doi-asserted-by":"publisher","unstructured":"Matysiak K, Szewczuk M, Hojdis A, et al. Immuno-Nutritional Profiling for Survival Stratification in Gastrectomized Patients with Malignant Chronic Intestinal Failure. Nutrients. 026;18(3). https:\/\/doi.org\/10.3390\/nu18030451.","DOI":"10.3390\/nu18030451"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04439-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04439-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04439-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:03:14Z","timestamp":1785848594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04439-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4439"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04439-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Ethics Committee of the Affiliated Hospital of Fujian Medical University (IRB No. 2014019), the Medical Ethics Committee of the Fifth Affiliated Hospital of Southern Medical University (IRB No. 2025-PTWK-K-001), and the Medical Research Ethics Review Committee of Ningxia Medical University General Hospital (IRB No. KYLL-2025-1794).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"322"}}